Managing risk and reducing attrition in pharmaceutical development: what's your strategy?
Bringing a medicine to market is an inherently costly and risky venture. When you consider that just one in ten drug compounds entering clinical trials ultimately receives regulatory approval, it’s important to understand that project failure is a very real prospect. Without careful planning, even an experienced developer
can find that significant amounts of time and resources have been invested in a program that has prematurely reached the end of the road.
One of the best ways to guard against poor development decisions and ensure programs deliver safe and effective products, on time and on budget, is to work with an experienced contract research organization. This will help ensure development strategies are designed to carefully manage exposure to risk and maximize the likelihood of success. Here, we take a look at some of the best ways to ensure your drug development program doesn’t become just another statistic.
Get your copy of our informative article from our expert Ciriaco Maraschiello, Vice President Pharmaceutical and Preclinical Development, today and discover more!